The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day-Reference-Cited by-同舟云学术

The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day

Published:2008-01 Issue:1-2 Volume:93 Page:132-140
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Somoza Eugene,Somoza Peggy,Lewis Daniel,Li Shou-Hua,Winhusen Theresa,Chiang Nora,Vocci Frank,Horn Paul,Elkashef Ahmed

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference25 articles.

1. Arrestee Drug Abuse Monitoring (ADAM) program report. National Institute of Justice. (accessed in 2006).

2. The urinary excretion of cocaine and metabolites in humans: a kinetic analysis of published data;Ambre;J. Anal. Toxicol.,1985

3. Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans;Ambre;J. Anal. Toxicol.,1988

4. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations;Batki;J. Clin. Psychopharmacol.,1993

5. Quantitative cocaine urine testing in clinical research settings;Crosby;Ann. Clin. Psychiatry,1991

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward Addiction Prediction: An Overview of Cross-Validated Predictive Modeling Findings and Considerations for Future Neuroimaging Research;Biological Psychiatry: Cognitive Neuroscience and Neuroimaging;2020-08

2. What happens to agreement over time? A longitudinal study of self-reported substance use compared to saliva toxicological testing among subsidized housing residents;Journal of Substance Abuse Treatment;2019-06

3. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda;Drug and Alcohol Dependence;2016-01

4. Toward empirical identification of a clinically meaningful indicator of treatment outcome: Features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes;Drug and Alcohol Dependence;2014-04

5. A Multisite, Double-blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Vigabatrin for Treating Cocaine Dependence;JAMA Psychiatry;2013-06-01